Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03878719
Title Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Array BioPharma



Binimetinib + Encorafenib

Age Groups: child
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Johns Hopkins Medicine Not yet recruiting Baltimore Maryland 21287 United States Details
UPMC Children's Hospital of Pittsburgh Recruiting Pittsburgh Pennsylvania 15224 United States Details
The University of Texas MD Anderson Cancer Center Not yet recruiting Houston Texas 77030 United States Details
Sydney Children's Hospital Not yet recruiting Sydney New South Wales 2031 Australia Details
The Childrens Hospital at Westmead Not yet recruiting Westmead New South Wales 2145 Australia Details
Monash University - Monash Health - Monash Medical Centre Not yet recruiting Clayton Victoria 3168 Australia Details
Sanatorium profesora Arenbergera Recruiting Praha 1 11000 Czechia Details
Lekarna U sv. Ignace Recruiting Praha 2 120 00 Czechia Details
Fondazione IRCCS Istituto Nazionale Dei Tumori Recruiting Milan Lombardy 20133 Italy Details
Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica Recruiting Siena Toscana 53100 Italy Details
AOU Citta della Salute e della Scienza- Presidio Ospedaliero Infantile Regina Margherita Not yet recruiting Torino Turin 10126 Italy Details
Istituto Nazionale per lo studio e la Cura dei tumori Fondazione Senatore Pascale Not yet recruiting Napoli 80131 Italy Details
Capital and Coast District Health Board Recruiting Wellington 6021 New Zealand Details
*Shaded cells indicate that there was no data available from for the field